WallStreetZenWallStreetZen

NASDAQ: BLPH
Bellerophon Therapeutics Inc Stock

$6.47-0.31 (-4.57%)
Updated Mar 17, 2023
BLPH Price
$6.47
Fair Value Price
$9.07
Market Cap
$61.76M
52 Week Low
$0.67
52 Week High
$7.88
P/E
-3.24x
P/B
8.31x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$19.09M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.7
Operating Cash Flow
-$17M
Beta
-0.27
Next Earnings
Mar 29, 2023
Ex-Dividend
N/A
Next Dividend
N/A

BLPH Overview

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BLPH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BLPH ($6.47) is undervalued by 28.69% relative to our estimate of its Fair Value price of $9.07 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BLPH ($6.47) is significantly undervalued by 28.69% relative to our estimate of its Fair Value price of $9.07 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
BLPH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BLPH due diligence checks available for Premium users.

Be the first to know about important BLPH news, forecast changes, insider trades & much more!

BLPH News

Valuation

BLPH fair value

Fair Value of BLPH stock based on Discounted Cash Flow (DCF)
Price
$6.47
Fair Value
$9.07
Undervalued by
28.69%
BLPH ($6.47) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BLPH ($6.47) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BLPH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BLPH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.24x
Industry
16.18x
Market
21.81x

BLPH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.31x
Industry
4.75x
BLPH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BLPH's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.1M
Profit Margin
0%
BLPH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$12.6M
Liabilities
$5.2M
Debt to equity
0.7
BLPH's short-term assets ($12.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BLPH's short-term assets ($12.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BLPH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BLPH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.0M
Investing
$0.0
Financing
$0.0
BLPH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BLPH vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BLPH$61.76M-4.57%-3.24x8.31x
PASG$61.17M+3.70%-0.45x0.30x
ENOB$62.39M+9.80%-0.54x0.93x
CNTB$63.17M-3.51%-0.63x0.31x
ELEV$60.35M+8.51%-0.62x1.23x

Bellerophon Therapeutics Stock FAQ

What is Bellerophon Therapeutics's quote symbol?

NASDAQ: BLPH) Bellerophon Therapeutics trades on the NASDAQ under the ticker symbol BLPH. Bellerophon Therapeutics stock quotes can also be displayed as NASDAQ: BLPH.

If you're new to stock investing, here's how to buy Bellerophon Therapeutics stock.

What is the 52 week high and low for Bellerophon Therapeutics (NASDAQ: BLPH)?

(NASDAQ: BLPH) Bellerophon Therapeutics's 52-week high was $7.88, and its 52-week low was $0.67. It is currently -17.89% from its 52-week high and 865.67% from its 52-week low.

How much is Bellerophon Therapeutics stock worth today?

(NASDAQ: BLPH) Bellerophon Therapeutics currently has 9,545,451 outstanding shares. With Bellerophon Therapeutics stock trading at $6.47 per share, the total value of Bellerophon Therapeutics stock (market capitalization) is $61.76M.

Bellerophon Therapeutics stock was originally listed at a price of $134.55 in Feb 13, 2015. If you had invested in Bellerophon Therapeutics stock at $134.55, your return over the last 8 years would have been -95.19%, for an annualized return of -31.57% (not including any dividends or dividend reinvestments).

How much is Bellerophon Therapeutics's stock price per share?

(NASDAQ: BLPH) Bellerophon Therapeutics stock price per share is $6.47 today (as of Mar 17, 2023).

What is Bellerophon Therapeutics's Market Cap?

(NASDAQ: BLPH) Bellerophon Therapeutics's market cap is $61.76M, as of Mar 20, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bellerophon Therapeutics's market cap is calculated by multiplying BLPH's current stock price of $6.47 by BLPH's total outstanding shares of 9,545,451.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.